Trial · NCT07889648
Registered outcomes25
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 25
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline to Week 72 in Glycosylated Hemoglobin (HbA1c, %) | Baseline through Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of ≤6.5% at Week 72 | At Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of <5.7% at Week 72 | At Week 72 | |
| Secondary | Change From Baseline to Week 72 in Fasting Glucose | Baseline through Week 72 | |
| Secondary | Percent Change From Baseline to Week 72 in Body Weight | Baseline through Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of <7% at Week 72 | At Week 72 | |
| Secondary | Change From Baseline to Week 72 in 7-Point Self-Monitoring Blood Glucose (SMBG) Profiles | Baseline through Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of <7% at Week 72 Without Clinically Significant, Documented Symptomatic Hypoglycemia, or Severe Hypoglycemia | At Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of <6.5% at Week 72 Without Clinically Significant, Documented Symptomatic Hypoglycemia, or Severe Hypoglycemia | At Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of <5.7% at Week 72 Without Clinically Significant, Documented Symptomatic Hypoglycemia, or Severe Hypoglycemia | At Week 72 | |
| Secondary | Percentage of Participants Achieving Weight Loss of ≥5% at Week 72 | At Week 72 | |
| Secondary | Percentage of Participants Achieving Weight Loss of ≥10% at Week 72 | At Week 72 | |
| Secondary | Percentage of Participants Achieving Weight Loss of ≥15% at Week 72 | At Week 72 | |
| Secondary | Change From Baseline to Week 72 in Waist Circumference | Baseline through Week 72 | |
| Secondary | Change From Baseline to Week 72 in Waist-to-Height Ratio | Baseline through Week 72 | |
| Secondary | Percentage of Participants Achieving HbA1c of ≤6.5% and Weight Loss of ≥10% at Week 72 | At Week 72 | |
| Secondary | Change From Baseline to Week 72 in Total Cholesterol | Baseline through Week 72 | |
| Secondary | Change from Baseline to Week 72 in Triglycerides | Baseline through Week 72 | |
| Secondary | Change from Baseline to Week 72 in Low-Density Lipoprotein Cholesterol (LDL-C) | Baseline through Week 72 | |
| Secondary | Change from Baseline to Week 72 in High-Density Lipoprotein Cholesterol (HDL-C) | Baseline through Week 72 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07889648/registered